drugset / Trial / NCT00359736

Sildenafil Study to Treat Idiopathic Pulmonary Fibrosis

NCT00359736

Phase 2 Completed 29 enrolled VA Office of Research and Development
RandomizedParallel-groupQuadruple-blindTreatment

Summary

Medicines that decrease blood pressure in the lungs may help idiopathic pulmonary fibrosis (IPF) patients function better. This study will test whether sildenafil improves the ability to exercise in patients with pulmonary fibrosis of unknown cause.

Timeline

Start
2006-07
Primary completion
2008-10
Completion
2009-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Sildenafil Unknown 20 mg Oral